Update on Regulatory Review of leriglitazone in the EU
Update on Regulatory Review of leriglitazone in the EU
Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Update on Regulatory Review of leriglitazone in the EU
By Sabela Ojea Intel on Thursday delivered a muted outlook for sales in its current quarter. Shares of the chipmaker dropped 10%, to $44.52, in after-hours trading. The Committee for...
By Sabela Ojea Intel on Thursday delivered a muted outlook for sales in its current quarter. Shares of the chipmaker dropped 10%, to $44.52, in after-hours...
By Chris Wack Apellis Pharmaceuticals said that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a negative...
LONDON (Reuters) -The EU's drug regulator said on Friday it would continue to review whether Novo Nordisk's popular weight-loss drug Wegovy could also be ...